Pro Nephro AKI (NGAL) is now FDA-Cleared READ MORE
✕
BioPorto is an agile, mission-driven company focused on launching novel biomarker tests designed to help improve patient outcomes.
You’re invited to connect with us on LinkedIn to learn about future opportunities, or check here for openings at our headquarters in Denmark.